Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

The purpose of this observational study is to collect additional information regarding long-term safety and effectiveness of Ilaris in the treatment of CAPS patients in clinical practice.

Lead sponsor: Novartis Pharmaceuticals•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITING

Ilaris NIS in Korea

NCT06838143 · Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 28, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment288

Start dateNov 2009

Last updatedMar 28, 2016

Condition

Cryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)Neonatal Onset Multisystem Inflam Disease (NOMID)

Locations shown

Little Rock Allergy and Asthma Clinic

Little Rock, Arizona

Allergy Center at Brookstone

Columbus, Georgia

Rush Presbyterian - St. Lukes Medical Center

Chicago, Illinois

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 28, 2016Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions